Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Bokemeyer

Showing results (501-510 of 664) with videos related to

Pageof 67
Sort By:
Oncotarget|April 8, 2015
Cyclooxygenase-2 blockade can improve efficacy of VEGF-targeting drugsIsabel Ben-Batalla, Miguel Cubas-Cordova, Florian Udonta, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 18, 2012
Heterogeneity of ERBB2 amplification in adenocarcinoma, squamous cell carcinoma and large cell undifferentiated carcinoma of the lungTobias J Grob, Ivonne Kannengiesser, Maria C Tsourlakis, et al.
Journal for Immunotherapy of Cancer|December 22, 2022
TIGIT blockade repolarizes AML-associated TIGIT<sup>+</sup> M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosisFranziska Brauneck, Brit Fischer, Marius Witt, et al.
Breast Cancer (Tokyo, Japan)|May 28, 2014
Cyclin D1 gene amplification is highly homogeneous in breast cancerEike Burandt, Martin Grünert, Annette Lebeau, et al.
Cancers|September 28, 2023
Daratumumab, Bortezomib, and Dexamethasone for Treatment of Patients with Relapsed or Refractory Multiple Myeloma and Severe Renal Impairment: Results from the Phase 2 GMMG-DANTE TrialLisa B Leypoldt, Maria Gavriatopoulou, Britta Besemer, et al.
Trials|May 7, 2026
Existential distress in advanced cancer: study protocol of a pragmatic randomized controlled trial of a short-term psychodynamic therapy (ORPHYS) compared to usual psycho-oncological treatment (TAU)Rebecca Philipp, Charlotte Walbaum, Carsten Bokemeyer, et al.
Blood Advances|December 4, 2020
Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patientsSusanne Ghandili, Susanne Pfefferle, Kevin Roedl, et al.
Haematologica|July 18, 2024
Multiple myeloma in the young: insights on prognosis, clinical features and treatment outcome derived from nationwide German registry data and a nested multicenter sampleAbdulaziz Kamili, Paymon Ahmadi, Lisa Leypoldt, et al.
BMJ Quality & Safety|October 16, 2024
Through the patients' eyes: psychometric evaluation of the 64-item version of the Experienced Patient-Centeredness Questionnaire (EPAT-64)Eva Christalle, Stefan Zeh, Hannah Führes, et al.
Marine Drugs|June 30, 2016
Pretrichodermamides D-F from a Marine Algicolous Fungus Penicillium sp. KMM 4672Anton N Yurchenko, Olga F Smetanina, Elena V Ivanets, et al.
Pageof 67

Showing results (501-510 of 664) with videos related to

Sort By:
Pageof 67
Oncotarget|April 8, 2015
Cyclooxygenase-2 blockade can improve efficacy of VEGF-targeting drugsIsabel Ben-Batalla, Miguel Cubas-Cordova, Florian Udonta, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 18, 2012
Heterogeneity of ERBB2 amplification in adenocarcinoma, squamous cell carcinoma and large cell undifferentiated carcinoma of the lungTobias J Grob, Ivonne Kannengiesser, Maria C Tsourlakis, et al.
Journal for Immunotherapy of Cancer|December 22, 2022
TIGIT blockade repolarizes AML-associated TIGIT<sup>+</sup> M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosisFranziska Brauneck, Brit Fischer, Marius Witt, et al.
Breast Cancer (Tokyo, Japan)|May 28, 2014
Cyclin D1 gene amplification is highly homogeneous in breast cancerEike Burandt, Martin Grünert, Annette Lebeau, et al.
Cancers|September 28, 2023
Daratumumab, Bortezomib, and Dexamethasone for Treatment of Patients with Relapsed or Refractory Multiple Myeloma and Severe Renal Impairment: Results from the Phase 2 GMMG-DANTE TrialLisa B Leypoldt, Maria Gavriatopoulou, Britta Besemer, et al.
Trials|May 7, 2026
Existential distress in advanced cancer: study protocol of a pragmatic randomized controlled trial of a short-term psychodynamic therapy (ORPHYS) compared to usual psycho-oncological treatment (TAU)Rebecca Philipp, Charlotte Walbaum, Carsten Bokemeyer, et al.
Blood Advances|December 4, 2020
Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patientsSusanne Ghandili, Susanne Pfefferle, Kevin Roedl, et al.
Haematologica|July 18, 2024
Multiple myeloma in the young: insights on prognosis, clinical features and treatment outcome derived from nationwide German registry data and a nested multicenter sampleAbdulaziz Kamili, Paymon Ahmadi, Lisa Leypoldt, et al.
BMJ Quality & Safety|October 16, 2024
Through the patients' eyes: psychometric evaluation of the 64-item version of the Experienced Patient-Centeredness Questionnaire (EPAT-64)Eva Christalle, Stefan Zeh, Hannah Führes, et al.
Marine Drugs|June 30, 2016
Pretrichodermamides D-F from a Marine Algicolous Fungus Penicillium sp. KMM 4672Anton N Yurchenko, Olga F Smetanina, Elena V Ivanets, et al.
Pageof 67